Review: is there a window of opportunity for treatment of systemic juvenile idiopathic arthritis?

Arthritis Rheumatol. 2014 Jun;66(6):1405-13. doi: 10.1002/art.38615.
No abstract available

Publication types

  • Review

MeSH terms

  • Adolescent
  • Animals
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Juvenile / drug therapy*
  • Child
  • Child, Preschool
  • Cytokines / antagonists & inhibitors*
  • Disease Models, Animal
  • Disease Progression
  • Humans
  • Interleukin 1 Receptor Antagonist Protein / therapeutic use*
  • Interleukin-1 / antagonists & inhibitors
  • Mice
  • Treatment Outcome

Substances

  • Antirheumatic Agents
  • Cytokines
  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-1